R. Gendreau

Cerephex Corp. develops and provides therapies and diagnostic technologies for chronic centralized pain. It offers NeuroPoint, a point-of-care medical device that is built upon patented reduced impedance noninvasive cortical electrostimulation signal technology platform developed to unable use by physician-supervised staff in existing clinical outpatient offices. The company was founded by Jeffrey Hargrove and Robert M. Ford on September 26, 2012 and is headquartered in Los Altos, CA.

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel.

Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.

Microprobe Corp. is an American company that specializes in commercial medical research.

Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH.